Carotenoid uptake and protection in cultured RPE

Carotenoids: Physical, Chemical, and Biological Functions and Properties

Volumn , Issue , 2009, Pages 309-354

  Różanowska, Małgorzata ^a   Różanowski, Bartosz ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b PEDAGOGICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; BONE; OPHTHALMOLOGY; VISION;

HUMAN BODIES; HUMAN DIET; MACULAR PIGMENTS; OUTER SEGMENTS; RETINAL PIGMENT EPITHELIUM; ZEAXANTHIN;

PIGMENTS;

EID: 84893394180     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420052312     Document Type: Chapter

References (377)

1. Acton, S, Rigotti, A, Landschulz, KT, Xu, S, Hobbs, HH, and Krieger, M, 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271, 518-520.
2. Adler, AJ and Edwards, RB, 2000. Human interphotoreceptor matrix contains serum albumin and retinolbinding protein. Exp Eye Res 70, 227-234.
3. Ahir, A, Guo, L, Hussain, AA, and Marshall, J, 2002. Expression of metalloproteinases from human retinal pigment epithelial cells and their effects on the hydraulic conductivity of Bruch’s membrane. Invest Ophthalmol Vis Sci 43, 458-465.
4. Aizman, A, Johnson, MW, and Elner, SG, 2007. Treatment of acute retinal necrosis syndrome with oral antiviral medications. Ophthalmology 114, 307-312.
5. Albanes, D, Heinonen, OP, Huttunen, JK, Taylor, PR, Virtamo, J, Edwards, BK, Haapakoski, J, Rautalahti, M, Hartman, AM, Palmgren, J, and Greenwald, P, 1995. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the alpha-tocopherol beta-carotene cancer prevention study. Am J Clin Nutr 62, S1427-S1430.
6. Aleman, TS, Duncan, JL, Bieber, ML, de Castro, E, Marks, DA, Gardner, LM, Steinberg, JD, Cideciyan, AV, Maguire, MG, and Jacobson, SG, 2001. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci 42, 1873-1881.
7. Alija, AJ, Bresgen, N, Sommerburg, O, Siems, W, and Eckl, PM, 2004. Cytotoxic and genotoxic effects of beta-carotene breakdown products on primary rat hepatocytes. Carcinogenesis 25, 827-831.
8. Alija, AJ, Bresgen, N, Sommerburg, O, Langhans, CD, Siems, W, and Eckl, PM, 2006. b-Carotene breakdown products enhance genotoxic effects of oxidative stress in primary rat hepatocytes. Carcinogenesis 27, 1128-1133.
9. Allikmets, R, Singh, N, Sun, H, Shroyer, NE, Hutchinson, A, Chidambaram, A, Gerrard, B et al. 1997. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 15, 236-246.
10. Allikmets, R, 2000. Simple and complex ABCR: Genetic predisposition to retinal disease. Am J Hum Genet 67, 793-799.
11. Anderson, DH, Ozaki, S, Nealon, M, Neitz, J, Mullins, RF, Hageman, GS, and Johnson, LV, 2001. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol 131, 767-781.
12. Anderson, DH, Mullins, RF, Hageman, GS, and Johnson, LV, 2002. Perspective—A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134, 411-431.
13. AREDS, 2001. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss, AREDS Report No. 8. Arch Ophthalmol 119, 1417-1436.
14. Arora, S, Musadiq, M, Mukherji, S, and Yang, YC, 2004. Eye nutrient products for age-related macular degeneration: what do they contain? Eye 18, 470-473.
15. Astley, SB, Elliott, RM, Archer, DB, and Southon, S, 2002. Increased cellular carotenoid levels reduce the persistence of DNA single-strand breaks after oxidative challenge. Nutr Cancer 43, 202-213.
16. Astley, SB, Elliott, RM, Archer, DB, and Southon, S, 2004a. Evidence that dietary supplementation with carotenoids and carotenoid-rich foods modulates the DNA damage: repair balance in human lymphocytes. Br J Nutr 91, 63-72.
17. Astley, SB, Hughes, DA, Wright, AJA, Elliott, RM, and Southon, S, 2004b. DNA damage and susceptibility to oxidative damage in lymphocytes: Effects of carotenoids in vitro and in vivo. Br J Nutr 91, 53-61.
18. Aukunuru, JV, Sunkara, G, Bandi, N, Thoreson, WB, and Kompella, UB, 2001. Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor. Pharm Res 18, 565-572.
19. Bahrami, H, Melia, M, and Dagnelie, G, 2006. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]. BMC Ophthalmol 6, 23.
20. Bailey, KR, Ishida, BY, Duncan, KG, Kane, JP, and Schwartz, DM, 2004. Basal reverse cholesterol transport of retinal pigment epithelium cell digested photoreceptor outer segment lipids. Invest Ophthalmol Vis Sci 45, U721.
21. Balazs, Z, Panzenboeck, U, Hammer, A, Sovic, A, Quehenberger, O, Malle, E, and Sattler, W, 2004. Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model. J Neurochem 89, 939-950.
22. Bartl, MM, Luckenbach, T, Bergner, O, Ullrich, O, and Koch-Brandt, C, 2001. Multiple receptors mediate apoJdependent clearance of cellular debris into nonprofessional phagocytes. Exp Cell Res 271, 130-141.
23. Baur, JA and Sinclair, DA, 2006. Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov 5, 493-506.
24. Beatty, S, Koh, HH, Henson, D, and Boulton, M, 2000. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45, 115-134.
25. Beatty, S, Nolan, J, Kavanagh, H, and O’Donovan, O, 2004. Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys 430, 70-76.
26. Beharry, S, Zhong, M, and Molday, RS, 2004. N-retinylidene-phosphatidylethanolamine is the preferred retinoid substrate for the photoreceptor-specific ABC transporter ABCA4 (ABCR). J Biol Chem 279, 53972-53979.
27. Ben-Dor, A, Steiner, M, Gheber, L, Danilenko, M, Dubi, N, Linnewiel, K, Zick, A, Sharoni, Y, and Levy, J, 2005. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 4, 177-186.
28. Berendschot, TT and van Norren, D, 2006. Macular pigment shows ringlike structures. Invest Ophthalmol Vis Sci 47, 709-714.
29. Berendschot, TTJM, Goldbohm, RA, Klopping, WAA, van de Kraats, J, van Norel, J, and van Norren, D, 2000. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41, 3322-3326.
30. Bernstein, PS, Balashov, NA, Tsong, ED, and Rando, RR, 1997. Retinal tubulin binds macular carotenoids. Invest Ophthalmol Vis Sci 38, 167-175.
31. Bernstein, PS, Khachik, F, Carvalho, LS, Muir, GJ, Zhao, DY, and Katz, NB, 2001. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res 72, 215-223.
32. Bernstein, PS, Leppert, M, Singh, N, Dean, M, Lewis, RA, Lupski, JR, Allikmets, R, and Seddon, JM, 2002a. Genotype-phenotype analysis of ABCR variants in macular degeneration probands and siblings. Invest Ophthalmol Vis Sci 43, 466-473.
33. Bernstein, PS, Zhao, DY, Wintch, SW, Ermakov, IV, McClane, RW, and Gellermann, W, 2002b. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 109, 1780-1787.
34. Bhatti, RA, Yu, S, Boulanger, A, Fariss, RN, Guo, Y, Bernstein, SL, Gentleman, S, and Redmond, TM, 2003. Expression of beta-carotene 15,15′ monooxygenase in retina and RPE-choroid. Invest Ophthalmol Vis Sci 44, 44-49.
35. Bhosale, P, Larson, AJ, Frederick, JM, Southwick, K, Thulin, CD, and Bernstein, PS., 2004. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem 279, 49447-49454.
36. Bhosale, P and Bernstein, PS, 2005. Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid membrane oxidation. Biochim Biophys Acta 1740, 116-121.
37. Bhosale, P and Bernstein, PS, 2007. Vertebrate and invertebrate carotenoid-binding proteins. Arch Biochem Biophys 458, 121-127.
38. Bhosale, P, Zhao da, Y, and Bernstein, PS, 2007a. HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era. Invest Ophthalmol Vis Sci 48, 543-549.
39. Bhosale, P, Zhao da, Y, Serban, B, and Bernstein, PS, 2007b. Identification of 3-methoxyzeaxanthin as a novel age-related carotenoid metabolite in the human macula. Invest Ophthalmol Vis Sci 48, 1435-1440.
40. Bjorkegren, J, Veniant, M, Kim, SK, Withycombe, SK, Wood, PA, Hellerstein, MK, Neese, RA, and Young, SG, 2001. Lipoprotein secretion and triglyceride stores in the heart. J Biol Chem 276, 38511-38517.
41. Blomhoff, R and Blomhoff, HK, 2006. Overview of retinoid metabolism and function. J Neurobiol 66, 606-630.
42. Bohm, F, Tinkler, JH, and Truscott, TG, 1995. Carotenoids protect against cell membrane damage by the nitrogen dioxide radical. Nat Med 1, 98-99.
43. Bohm, F, Edge, R, Lange, L, and Truscott, TG, 1998a. Enhanced protection of human cells against ultraviolet light by antioxidant combinations involving dietary carotenoids. J Photochem Photobiol B 44, 211-215.
44. Bohm, F, Edge, R, McGarvey, DJ, and Truscott, TG, 1998b. Beta-carotene with vitamins E and C offers synergistic cell protection against NOx. FEBS Lett 436, 387-389.
45. Bohm, F, Edge, R, Foley, S, Lange, L, and Truscott, TG, 2001. Antioxidant inhibition of porphyrin-induced cellular phototoxicity. J Photochem Photobiol B 65, 177-183.
46. Bone, RA, Landrum, JT, Fernandez, L, and Tarsis, SL, 1988. Analysis of the macular pigment by HPLC: Retinal distribution and age study. Invest Ophthalmol Vis Sci 29, 843-849.
47. Bone, RA and Landrum, JT, 1992. Distribution of macular pigment components, zeaxanthin and lutein, in human retina. Methods Enzymol 213, 360-366.
48. Bone, RA, Landrum, JT, and Cains, A, 1992. Optical density spectra of the macular pigment in vivo and in vitro. Vision Res 32, 105-110.
49. Bone, RA, Landrum, JT, Hime, GW, Cains, A, and Zamor, J, 1993. Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 34, 2033-2040.
50. Bone, RA, Landrum, JT, Friedes, LM, Gomez, CM, Kilburn, MD, Menendez, E, Vidal, I., and Wang, W., 1997. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 64, 211-218.
51. Bone, RA, Landrum, JT, Dixon, Z, Chen, Y, and Llerena, CM, 2000. Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res 71, 239-245.
52. Bone, RA, Landrum, JT, Mayne, ST, Gomez, CM, Tibor, SE, and Twaroska, EE, 2001. Macular pigment in donor eyes with and without AMD: A case-control study. Invest Ophthalmol Vis Sci 42, 235-240.
53. Bone, RA, Landrum, JT, Guerra, LH, and Ruiz, CA, 2003. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 133, 992-998.
54. Boulton, M, Rozanowska, M, and Rozanowski, B, 2001. Retinal photodamage. J Photochem Photobiol B 64, 144-161.
55. Boulton, M, Rozanowska, M, Rozanowski, B, and Wess, T, 2004. The photoreactivity of ocular lipofuscin. Photochem Photobiol Sci 3, 759-764.
56. Breithaupt, DE and Schlatterer, J, 2005. Lutein and zeaxanthin in new dietary supplements—Analysis and quantification. Eur Food Res Technol 220, 648-652.
57. Britton, G, 1995. UV/visible spectroscopy. In: Britton, G, Liaaen-Jensen, S, and Pfander, H. (Eds.), Carotenoids. Birkhauser, Basel, Switzerland, pp. 13-62.
58. Brown, AJ and Fragoso, YD, 1994. Tocopherols and carotenes are differently distributed in subfractions of high-density lipoprotein. Biochim Biophys Acta 1210, 373-376.
59. Browning, PJ, Roberts, DD, Zabrenetzky, V, Bryant, J, Kaplan, M, Washington, RH, Panet, A, Gallo, RC, and Vogel, T, 1994. Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi’s sarcoma-like lesions in BALB/c nu/nu mice. J Exp Med 180, 1949-1954.
60. Bultel-Brienne, S, Lestavel, S, Pilon, A, Laffont, I, Tailleux, A, Fruchart, JC, Siest, G, and Clavey, V, 2002. Lipid free apolipoprotein E binds to the class B type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins. J Biol Chem 277, 36092-36099.
61. Burke, M, Edge, R, Land, EJ, McGarvey, DJ, and Truscott, TG, 2001. One-electron reduction potentials of dietary carotenoid radical cations in aqueous micellar environments. FEBS Lett 500, 132-136.
62. Burton, GW and Ingold, KU, 1984. Beta-carotene: An unusual type of lipid antioxidant. Science 224, 569-573.
63. Calvo, D, Gomez-Coronado, D, Lasuncion, MA, and Vega, MA, 1997. CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins. Arterioscler Thromb Vasc Biol 17, 2341-2349.
64. Calvo, D, Gomez-Coronado, D, Suarez, Y, Lasuncion, MA, and Vega, MA, 1998. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 39, 777-788.
65. Cangemi, FE, 2007. TOZAL Study: An open case control study of an oral antioxidant and omega-3 supplement for dry AMD. BMC Ophthalmol 7, 3.
66. Cantrell, A, McGarvey, DJ, Truscott, TG, Rancan, F, and Bohm, F, 2003. Singlet oxygen quenching by dietary carotenoids in a model membrane environment. Arch Biochem Biophys 412, 47-54.
67. Cardinault, N, Abalain, JH, Sairafi, B, Coudray, C, Grolier, P, Rambeau, M, Carre, JL, Mazur, A, and Rock, E, 2005. Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients. Clinica Chimica Acta 357, 34-42.
68. Cecchelli, R, Berezowski, V, Lundquist, S, Culot, M, Renftel, M, Dehouck, MP, and Fenart, L, 2007. Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 6, 650-661.
69. Chan, A, Ko, TH, and Duker, JS, 2006. Ultrahigh-resolution optical coherence tomography of canthaxanthine retinal crystals. Ophthalmic Surg Lasers Imaging 37, 138-139.
70. Chen, JY, Cheung, NH, Fung, MC, Wen, JM, Leung, WN, and Mak, NK, 2000. Subcellular localization of merocyanine 540 (MC540) and induction of apoptosis in murine myeloid leukemia cells. Photochem Photobiol 72, 114-120.
71. Chen, M, Forrester, JV, and Xu, H, 2007. Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Exp Eye Res 84, 635-645.
72. Chen, W, Sun, Y, Welch, C, Gorelik, A, Leventhal, AR, Tabas, I, and Tall, AR, 2001. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. J Biol Chem 276, 43564-43569.
73. Cheng, HC, Chien, H, Liao, CH, Yang, YY, and Huang, SY, 2007. Carotenoids suppress proliferating cell nuclear antigen and cyclin D1 expression in oral carcinogenic models. J Nutr Biochem 18, 667-675.
74. Chew, BP, Brown, CM, Park, JS, and Mixter, PF, 2003. Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis. Anticancer Res 23, 3333-3339.
75. Chew, BP and Park, JS, 2004. Carotenoid action on the immune response. J Nutr 134, 257S-261S.
76. Chichili, GR, Nohr, D, Schaffer, M, von Lintig, J, and Biesalski, HK, 2005. Beta-carotene conversion into vitamin A in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 46, 3562-3569.
77. Chichili, GR, Nohr, D, Frank, J, Flaccus, A, Fraser, PD, Enfissi, EM, and Biesalski, HK, 2006. Protective effects of tomato extract with elevated beta-carotene levels on oxidative stress in ARPE-19 cells. Br J Nutr 96, 643-649.
78. Cho, E, Seddon, JM, Rosner, B, Willett, WC, and Hankinson, SE, 2004. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol 122, 883-892.
79. Choi, JS, Kim, D, Hong, YM, Mizuno, S, and Joo, CK, 2006. Inhibition of nNOS and COX-2 expression by lutein in acute retinal ischemia. Nutrition 22, 668-671.
80. Chong, EW, Wong, TY, Kreis, AJ, Simpson, JA, and Guymer, RH, 2007. Dietary antioxidants and primary prevention of age related macular degeneration: Systematic review and meta-analysis. BMJ 335, 755.
81. Chowers, I, Wong, R, Dentchev, T, Farkas, RH, Iacovelli, J, Gunatilaka, TL, Medeiros, NE, Presley, JB, Campochiaro, PA, Curcio, CA, Dunaief, JL, and Zack, DJ, 2006. The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 47, 2135-2140.
82. Chucair, AJ, Rotstein, NP, Sangiovanni, JP, During, A, Chew, EY, and Politi, LE, 2007. Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: Relation with docosahexaenoic acid. Invest Ophthalmol Vis Sci 48, 5168-5177.
83. Coleman, H and Chew, E, 2007. Nutritional supplementation in age-related macular degeneration. Curr Opin Ophthalmol 18, 220-223.
84. Connor, WE, Duell, PB, Kean, R, and Wang, Y, 2007. The prime role of HDL to transport lutein into the retina: Evidence from HDL-deficient WHAM chicks having a mutant ABCA1 transporter. Invest Ophthalmol Vis Sci 48, 4226-4231.
85. Constable, PA, Lawrenson, JG, Dolman, DE, Arden, GB, and Abbott, NJ, 2006. P-Glycoprotein expression in human retinal pigment epithelium cell lines. Exp Eye Res 83, 24-30.
86. Coral-Hinostroza, GN, Ytrestoyl, T, Ruyter, B, and Bjerkeng, B, 2004. Plasma appearance of unesterified astaxanthin geometrical E/Z and optical R/S isomers in men given single doses of a mixture of optical 3 and 3′ R/S isomers of astaxanthin fatty acyl diesters. Comp Biochem Physiol C-Toxicol Pharmacol 139, 99-110.
87. Costet, P, Lalanne, F, Gerbod-Giannone, MC, Molina, JR, Fu, X, Lund, EG, Gudas, LJ, and Tall, AR, 2003. Retinoic acid receptor-mediated induction of ABCA1 in macrophages. Mol Cell Biol 23, 7756-7766.
88. Crabb, JW, Miyagi, M, Gu, X, Shadrach, K, West, KA, Sakaguchi, H, Kamei, M, Hasan, A, Yan, L, Rayborn, ME, Salomon, RG, and Hollyfield, JG, 2002. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 99, 14682-14687.
89. Crane, IJ, Wallace, CA, McKillop-Smith, S, and Forrester, JV, 2000a. Control of chemokine production at the blood-retina barrier. Immunology 101, 426-433.
90. Crane, IJ, Wallace, CA, McKillop-Smith, S, and Forrester, JV, 2000b. CXCR4 receptor expression on human retinal pigment epithelial cells from the blood-retina barrier leads to chemokine secretion and migration in response to stromal cell-derived factor 1 alpha. J Immunol 165, 4372-4378.
91. Cui, HS, Hayasaka, S, Zhang, XY, Hayasaka, Y, Chi, ZL, and Zheng, LS, 2006. Effect of berberine on interleukin 8 and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line. Ophthalmic Res 38, 149-157.
92. Dasch, B, Fuhs, A, Behrens, T, Meister, A, Wellmann, J, Fobker, M, Pauleikhoff, D, and Hense, HW, 2005. Inflammatory markers in age-related maculopathy—Cross-sectional analysis from the Muenster Aging and Retina Study. Arch Ophthalmol 123, 1501-1506.
93. Davies, NP and Morland, AB, 2004. Macular pigments: Their characteristics and putative role. Prog Retin Eye Res 23, 533-559.
94. Delcourt, C, Carriere, I, Delage, M, Barberger-Gateau, P, and Schalch, W, 2006. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: The POLA Study. Invest Ophthalmol Vis Sci 47, 2329-2335.
95. Dentchev, T, Hahn, P, and Dunaief, JL, 2005. Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration. Arch Ophthalmol 123, 1745-1746.
96. Dinkova-Kostova, AT and Talalay, P, 2008. Direct and indirect antioxidant properties of inducers of cytoprotective proteins, Mol Nutr Food Res 52 Suppl, S128-S138.
97. Donaldson, MJ and Pulido, JS, 2006. Treatment of nonexudative (dry) age-related macular degeneration. Curr Opin Ophthalmol 17, 267-274.
98. Donoso, LA, Kim, D, Frost, A, Callahan, A, and Hageman, G, 2006. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 51, 137-152.
99. Duncan, KG, Bailey, KR, Kane, JP, and Schwartz, DM, 2002. Human retinal pigment epithelial cells express scavenger receptors BI and BII. Biochem Biophys Res Commun 292, 1017-1022.
100. Dunn, KC, Aotaki-Keen, AE, Putkey, FR, and Hjelmeland, LM, 1996. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62, 155-169.
101. During, A, and Harrison, EH, 2007. Mechanisms of provitamin A (carotenoid) and vitamin A (retinol) transport into and out of intestinal Caco-2 cells. J Lipid Res 48, 2283-2294.
102. Ebihara, N, Chen, L, Tokura, T, Ushio, H, Iwatsu, M, and Murakami, A, 2007. Distinct functions between toll-like receptors 3 and 9 in retinal pigment epithelial cells. Ophthalmic Res 39, 155-163.
103. Edge, R, Land, EJ, McGarvey, D, Mulroy, L, and Truscott, TG, 1998. Relative one-electron reduction potentials of carotenoid radical cations and the interactions of carotenoids with the vitamin E radical cation. J Am Chem Soc 120, 4087-4090.
104. Edge, R, Land, EJ, McGarvey, DJ, Burke, M, and Truscott, TG, 2000a. The reduction potential of the beta-carotene+ /beta-carotene couple in an aqueous micro-heterogeneous environment. FEBS Lett 471, 125-127.
105. Edge, R, Land, EJ, Rozanowska, M, Sarna, T, and Truscott, TG, 2000b. Carotenoid radical-melanin interactions. J Phys Chem B 104, 7193-7196.
106. Edwards, AO, 2008. Genetics of age-related macular degeneration. Recent Advances in Retinal Degeneration 613, 211-219.
107. Ekam, VS, Udosen, EO, and Chigbu, AE, 2006. Comparative effect of carotenoid complex from Golden Neo-Life Dynamite (GNLD) and carrot extracted carotenoids on immune parameters in albino Wistar rats. Niger J Physiol Sci 21, 1-4.
108. El-Agamey, A, Cantrell, A, Land, EJ, McGarvey, DJ, and Truscott, TG, 2004a. Are dietary carotenoids beneficial? Reactions of carotenoids with oxy-radicals and singlet oxygen. Photochem Photobiol Sci 3, 802-811.
109. El-Agamey, A, Lowe, GM, McGarvey, DJ, Mortensen, A, Phillip, DM, Truscott, TG, and Young, AJ, 2004b. Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch Biochem Biophys 430, 37-48.
110. Ellis, EM, 2007. Reactive carbonyls and oxidative stress: Potential for therapeutic intervention. Pharmacol Ther 115, 13-24.
111. Elner, SG, Delmonte, D, Bian, ZM, Lukacs, NW, and Elner, VM, 2006. Differential expression of retinal pigment epithelium (RPE) IP-10 and interleukin-8. Exp Eye Res 83, 374-379.
112. Elner, VM, 2002. Retinal pigment epithelial acid lipase activity and lipoprotein receptors: Effects of dietary omega-3 fatty acids. Trans Am Ophthalmol Soc 100, 301-338.
113. Ershov, AV and Bazan, NG, 2000. Photoreceptor phagocytosis selectively activates PPARgamma expression in retinal pigment epithelial cells. J Neurosci Res 60, 328-337.
114. Espaillat, A, Aiello, LP, Arrigg, PG, Villalobos, R, Silver, PM, and Cavicchi, RW, 1999. Canthaxanthine retinopathy. Arch Ophthalmol 117, 412-413.
115. Esser, P, Tervooren, D, Heimann, K, Kociok, N, Bartz-Schmidt, KU, Walter, P, and Weller, M, 1998. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 39, 164-170.
116. Eter, N, Krohne, TU, and Holz, FG, 2006. New pharmacologic approaches to therapy for age-related macular degeneration. BioDrugs 20, 167-179.
117. Evans, JR, 2006. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev 19(2): CD000254.
118. Everett, SA, Dennis, MF, Patel, KB, Maddix, S, Kundu, SC, and Willson, RL, 1996. Scavenging of nitrogen dioxide, thiyl, and sulfonyl free radicals by the nutritional antioxidant beta-carotene. J Biol Chem 271, 3988-3994.
119. Failloux, N, Bonnet, I, Baron, MH, and Perrier, E, 2003. Quantitative analysis of vitamin A degradation by Raman spectroscopy. Appl Spectrosc 57, 1117-1122.
120. Faulkner, LE, Panagotopulos, SE, Johnson, JD, Woollett, LA, Hui, DY, Witting, SR, Maiorano, JN, and Davidson, WS, 2008. An analysis of the role of a retroendocytosis pathway in ATP-binding cassette transporter (ABCA1)—Mediated cholesterol efflux from macrophages. J Lipid Res, M800048-JLR800200.
121. Fiedor, J, Fiedor, L, Haessner, R, and Scheer, H, 2005. Cyclic endoperoxides of beta-carotene, potential pro-oxidants, as products of chemical quenching of singlet oxygen. Biochim Biophys Acta-Bioenerg 1709, 1-4.
122. Fuller, CJ, Faulkner, H, Bendich, A, Parker, RS, and Roe, DA, 1992. Effect of beta-carotene supplementation on photosuppression of delayed-type hypersensitivity in normal young men. Am J Clin Nutr 56, 684-690.
123. Gajic, M, Zaripheh, S, Sun, FR, and Erdman, JW, 2006. Apo-8′-lycopenal and apo-12′-lycopenal are metabolic products of lycopene in rat liver. J Nutr 136, 1552-1557.
124. Gale, CR, Hall, NF, Phillips, DI, and Martyn, CN, 2003. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 44, 2461-2465.
125. Girotti, AW and Korytowski, W, 2000. Cholesterol as a singlet oxygen detector in biological systems. Methods Enzymol 319, 85-100.
126. Godley, BF, Shamsi, FA, Liang, FQ, Jarrett, SG, Davies, S, and Boulton, M, 2005. Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J Biol Chem 280, 21061-21066.
127. Golczak, M, Imanishi, Y, Kuksa, V, Maeda, T, Kubota, R, and Palczewski, K, 2005a. Lecithin: Retinol acyltransferase is responsible for amidation of retinylamine, a potent inhibitor of the retinoid cycle. J Biol Chem 280, 42263-42273.
128. Golczak, M, Kuksa, V, Maeda, T, Moise, AR, and Palczewski, K, 2005b. Positively charged retinoids are potent and selective inhibitors of the trans-cis isornerization in the retinoid (visual) cycle. Proc Natl Acad Sci U S A 102, 8162-8167.
129. Goldberg, J, Flowerdew, G, Smith, E, Brody, JA, and Tso, MO, 1988. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 128, 700-710.
130. Goralczyk, R, Buser, S, Bausch, J, Bee, W, Zuhlke, U, and Barker, FM, 1997. Occurrence of birefringent retinal inclusions in cynomolgus monkeys after high doses of canthaxanthin. Invest Ophthalmol Vis Sci 38, 741-752.
131. Goralczyk, R, Barker, FM, Buser, S, Liechti, H, and Bausch, J, 2000. Dose dependency of canthaxanthin crystals in monkey retina and spatial distribution of its metabolites. Invest Ophthalmol Vis Sci 41, 1513-1522.
132. Gordiyenko, N, Campos, M, Lee, JW, Fariss, RN, Sztein, J, and Rodriguez, IR, 2004. RPE cells internalize low-density lipoprotein (LDL) and oxidized LDL (oxLDL) in large quantities in vitro and in vivo. Invest Ophthalmol Vis Sci 45, 2822-2829.
133. Gorin, MB, 2007. A clinician’s view of the molecular genetics of age-related maculopathy. Arch Ophthalmol 125, 21-29.
134. Gu, XR, Meer, SG, Miyagi, M, Rayborn, ME, Hollyfield, JG, Crabb, JW, and Salomon, RG, 2003. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 278, 42027-42035.
135. Gunasekera, RS, Sewgobind, K, Desai, S, Dunn, L, Black, HS, McKeehan, WL, and Patil, B, 2007. Lycopene and lutein inhibit proliferation in rat prostate carcinoma cells. Nutr Cancer 58, 171-177.
136. Guymer, RH and Chong, EW, 2006. Modifiable risk factors for age-related macular degeneration. Med J Aust 184, 455-458.
137. Hageman, GS, Luthert, PJ, Chong, NHV, Johnson, LV, Anderson, DH, and Mullins, RF, 2001. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20, 705-732.
138. Hahn, P, Milam, AH, and Dunaief, JL, 2003. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch’s membrane. Arch Ophthalmol 121, 1099-1105.
139. Haimovici, R, Kramer, M, Miller, JW, Hasan, T, Flotte, TJ, Schomacker, KT, and Gragoudas, ES, 1997. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr Eye Res 16, 83-90.
140. Halliwell, B and Gutteridge, JMC, 2000. Free Radicals in Biology and Medicine. Oxford University Press, Oxford.
141. Hammond, BR, Fuld, K, and Currancelentano, J, 1995. Macular pigment density in monozygotic twins. Invest Ophthalmol Vis Sci 36, 2531-2541.
142. Hammond, BR, Johnson, EJ, Russell, RM, Krinsky, NI, Yeum, KJ, Edwards, RB, and Snodderly, DM, 1997. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 38, 1795-1801.
143. Handelman, GJ, Snodderly, DM, Krinsky, NI, Russett, MD, and Adler, AJ, 1991a. Biological control of primate macular pigment—Biochemical and densitometric studies. Invest Ophthalmol Vis Sci 32, 257-267.
144. Handelman, GJ, Vankuijk, F, Chatterjee, A, and Krinsky, NI, 1991b. Characterization of products formed during the autoxidation of beta-carotene. Free Radic Biol Med 10, 427-437.
145. Haught, JM, Patel, S, and English, JC, 3rd, 2007. Xanthoderma: A clinical review. J Am Acad Dermatol 57, 1051-1058.
146. Hayes, JD, Flanagan, JU, and Jowsey, IR, 2005. Glutathione transferases. Annu Rev Pharmacol Toxicol 45, 51-88.
147. He, X, Hahn, P, Iacovelli, J, Wong, R, King, C, Bhisitkul, R, Massaro-Giordano, M, and Dunaief, JL, 2007. Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res 26, 649-673.
148. Hollyfield, JG, Salomon, RG, and Crabb, JW, 2003. Proteomic approaches to understanding age-related macular degeneration, In: LaVail, MM, Anderson, RE, and Hollyfield, JG (Eds.), Retinal Degenerations: Mechanisms and Experimental Therapy. Kluwer Academic/Plenum Publishers, New York, pp. 83-89.
149. Holtkamp, GM, Kijlstra, A, Peek, R, and de Vos, AF, 2001. Retinal pigment epithelium-immune system interactions: Cytokine production and cytokine-induced changes. Prog Retin Eye Res 20, 29-48.
150. Holz, FG, Bindewald-Wittich, A, Fleckenstein, M, Dreyhaupt, J, Scholl, HP, and Schmitz-Valckenberg, S, 2007. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol 143, 463-472.
151. Horak, P, Zilmer, M, Saks, L, Ots, I, Karu, U, and Zilmer, K, 2006. Antioxidant protection, carotenoids and the costs of immune challenge in greenfinches. J Exp Biol 209, 4329-4338.
152. Hozawa, A, Jacobs, DR, Jr., Steffes, MW, Gross, MD, Steffen, LM, and Lee, DH, 2007. Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: The Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) study. Clin Chem 53, 447-455.
153. Hu, W, Jiang, A, Liang, J, Meng, H, Chang, B, Gao, H, and Qiao, X, 2008. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model’s retinal angiomatous proliferation. Invest Ophthalmol Vis Sci 49, 407-415.
154. Hurst, JS, Contreras, JE, Siems, WG, and van Kuijk, F, 2004. Oxidation of carotenoids by heat and tobacco smoke. Biofactors 20, 23-35.
155. Hurst, JS, Saini, MK, Jin, GF, Awasthi, YC, and van Kuijk, FJ, 2005. Toxicity of oxidized beta-carotene to cultured human cells. Exp Eye Res 81, 239-243.
156. Hussein, G, Sankawa, U, Goto, H, Matsumoto, K, and Watanabe, H, 2006. Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod 69, 443-449.
157. Iannaccone, A, Mura, M, Gallaher, KT, Johnson, EJ, Todd, WA, Kenyon, E, Harris, TL, Harris, T, Satterfield, S, Johnson, KC, and Kritchevsky, SB, 2007. Macular pigment optical density in the elderly: Findings in a large biracial Midsouth population sample. Invest Ophthalmol Vis Sci 48, 1458-1465.
158. Ishida, BY, Bailey, KR, Duncan, KG, Chalkley, RJ, Burlingame, AL, Kane, JP, and Schwartz, DM, 2004. Regulated expression of apolipoprotein E by human retinal pigment epithelial cells. J Lipid Res 45, 263-271.
159. Ishida, BY, Duncan, KG, Bailey, KR, Kane, JP, and Schwartz, DM, 2006. High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture. Br J Ophthalmol 90, 616-620.
160. Izumi-Nagai, K, Nagai, N, Ohgami, K, Satofuka, S, Ozawa, Y, Tsubota, K, Umezawa, K, Ohno, S, Oike, Y, and Ishida, S, 2007. Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol 27, 2555-2562.
161. Jackson, GR, Owsley, C, and McGwin, G, 1999. Aging and dark adaptation. Vision Res 39, 3975-3982.
162. Jackson, GR, Owsley, C, and Curcio, CA, 2002. Photoreceptor degeneration and dysfunction in aging and age-related maculopathy. Ageing Res Rev 1, 381-396.
163. Jackson, GR, McGwin, G, Phillips, JM, Klein, R, and Owsley, C, 2006. Impact of aging and age-related maculopathy on inactivation of the a-wave of the rod-mediated electroretinogram. Vision Res 46, 1422-1431.
164. Ji, Y, Jian, B, Wang, N, Sun, Y, Moya, ML, Phillips, MC, Rothblat, GH, Swaney, JB, and Tall, AR, 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 272, 20982-20985.
165. Jin, XH, Ohgami, K, Shiratori, K, Suzuki, Y, Hirano, T, Koyama, Y, Yoshida, K, Ilieva, I, Iseki, K, and Ohno, S, 2006. Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci 47, 2562-2568.
166. Joffre, C, Leclere, L, Buteau, B, Martine, L, Cabaret, S, Malvitte, L, Acar, N, Lizard, G, Bron, A, and Creuzot-Garcher, C, 2007. Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. Curr Eye Res 32, 271-280.
167. Johnson, LV, Ozaki, S, Staples, MK, Erickson, PA, and Anderson, DH, 2000. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 70, 441-449.
168. Johnson, LV, Leitner, WP, Staples, MK, and Anderson, DH, 2001. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res 73, 887-896.
169. Jones, AA, 2007. Age related macular degeneration—Should your patients be taking additional supplements? Aust Fam Physician 36, 1026-1028.
170. Kaempf-Rotzoll, DE, Traber, MG, and Arai, H, 2003. Vitamin E and transfer proteins. Curr Opin Lipidol 14, 249-254.
171. Kalariya, NM, Ramana, KV, Srivastava, SK, and van Kuijk, FJ, 2008. Carotenoid derived aldehydes-induced oxidative stress causes apoptotic cell death in human retinal pigment epithelial cells. Exp Eye Res 86, 70-80.
172. Kaminski, WE, Wenzel, JJ, Piehler, A, Langmann, T, and Schmitz, G, 2001. ABCA6, a novel a subclass ABC transporter. Biochem Biophys Res Commun 285, 1295-1301.
173. Kanis, MJ, Berendschot, TT, and van Norren, D, 2007. Influence of macular pigment and melanin on incident early AMD in a white population. Graefes Arch Clin Exp Ophthalmol 245, 767-773.
174. Kanofsky, JR and Sima, PD, 2006. Synthetic carotenoid derivatives prevent photosensitised killing of retinal pigment epithelial cells more effectively than lutein. Exp Eye Res 82, 907-914.
175. Karl, MO, Valtink, M, Bednarz, J, and Engelmann, K, 2007. Cell culture conditions affect RPE phagocytic function. Graefes Arch Clin Exp Ophthalmol 245, 981-991.
176. Katz, ML, 2002. Potential role of retinal pigment epithelial lipofuscin accumulation in age-related macular degeneration. Arch Gerontol Geriatr 34, 359-370.
177. Kelly, ME, Clay, MA, Mistry, MJ, Hsieh-Li, HM, and Harmony, JA, 1994. Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: Production of interleukin 2 with reduced biological activity. Cell Immunol 159, 124-139.
178. Kelly, SP, Thornton, J, Lyratzopoulos, G, Edwards, R, and Mitchell, P, 2004. Smoking and blindness—Strong evidence for the link, but public awareness lags. Br Med J 328, 537-538.
179. Kennedy, BG and Mangini, NJ, 2002. P-glycoprotein expression in human retinal pigment epithelium. Mol Vis 8, 422-430.
180. Kennedy, TA and Liebler, DC, 1991. Peroxyl radical oxidation of beta-carotene—Formation of beta-carotene epoxides. Chem Res Toxicol 4, 290-295.
181. Khachik, F, Bernstein, PS, and Garland, DL, 1997. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 38, 1802-1811.
182. Khachik, F, de Moura, FF, Zhao, DY, Aebischer, CP, and Bernstein, PS, 2002. Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest Ophthalmol Vis Sci 43, 3383-3392.
183. Khachik, F, de Moura, FF, Chew, EY, Douglass, LW, Ferris, FL, 3rd, Kim, J, and Thompson, DJ, 2006. The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older. Invest Ophthalmol Vis Sci 47, 5234-5242.
184. Kijlstra, A, La Heij, EC, and Hendrikse, F, 2005. Immunological factors in the pathogenesis and treatment of age-related macular degeneration. Ocul Immunol Inflamm 13, 3-11.
185. Kim, SJ, Nara, E, Kobayashi, H, Terao, J, and Nagao, A, 2001. Formation of cleavage products by autoxidation of lycopene. Lipids 36, 191-199.
186. Kim, SJ, 2004. Cleavage products formed through autoxidation of zeta-carotene in liposomal suspension. Food Sci Biotechnol 13, 202-207.
187. Kim, WS, Weickert, CS, and Garner, B, 2008. Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. J Neurochem 104, 1145-1166.
188. Kiser, AK and Dagnelie, G, 2008. Reported effects of non-traditional treatments and complementary and alternative medicine by retinitis pigmentosa patients. Clin Exp Optom 91, 166-176.
189. Klamt, F, Dal-Pizzol, F, Roehrs, R, de Oliveira, RB, Dalmolin, R, Henriques, JAP, de Andrades, HHR, Ramos, A, Saffi, J, and Moreira, JCF, 2003. Genotoxicity, recombinogenicity and cellular preneoplasic transformation induced by vitamin A supplementation. Mutat Res Genet Toxicol Environ Mutagen 539, 117-125.
190. Klein, R, Klein, BEK, and Moss, SE, 1998. Relation of smoking to the incidence of age-related maculopathy— The Beaver Dam Eye Study. Am J Epidemiol 147, 103-110.
191. Koh, HH, Murray, IJ, Nolan, D, Carden, D, Feather, J, and Beatty, S, 2004. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: A pilot study. Exp Eye Res 79, 21-27.
192. Koldamova, RP, Lefterov, IM, Ikonomovic, MD, Skoko, J, Lefterov, PI, Isanski, BA, DeKosky, ST, and Lazo, JS, 2003. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J Biol Chem 278, 13244-13256.
193. Kotake-Nara, E, Kim, SJ, Kobori, M, Miyashita, K, and Nagao, A, 2002. Acyclo-retinoic acid induces apoptosis in human prostate cancer cells. Anticancer Res 22, 689-695.
194. Koutsos, EA, Garcia Lopez, JC, and Klasing, KC, 2007. Maternal and dietary carotenoids interactively affect cutaneous basophil responses in growing chickens (Gallus gallus domesticus). Comp Biochem Physiol B Biochem Mol Biol 147, 87-92.
195. Krieger, M, 1999. Charting the fate of the “good cholesterol”: Identification and characterization of the highdensity lipoprotein receptor SR-BI. Annu Rev Biochem 68, 523-558.
196. Krieger, M, 2001. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest 108, 793-797.
197. Krinsky, NI, Landrum, JT, and Bone, RA, 2003. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 23, 171-201.
198. Kuehn, BM, 2005. Inflammation suspected in eye disorders. J Am Med Assoc 294, 31-32.
199. Kuimova, MK, Yahioglu, G, and Ogilby, PR, 2009. Singlet oxygen in a cell: Spatially dependent lifetimes and quenching rate constants. J Am Chem Soc 131, 332-340.
200. Kvansakul, J, Rodriguez-Carmona, M, Edgar, DF, Barker, FM, Kopcke, W, Schalch, W, and Barbur, JL, 2006. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. Ophthalmic Physiol Opt 26, 362-371.
201. Lakkaraju, A, Finnemann, SC, and Rodriguez-Boulan, E, 2007. The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells. Proc Natl Acad Sci U S A 104, 11026-11031.
202. Lamb, TD and Pugh, EN, 2004. Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res 23, 307-380.
203. Landrum, JT, Bone, RA, Joa, H, Kilburn, MD, Moore, LL, and Sprague, KE, 1997. A one year study of the macular pigment: The effect of 140 days of a lutein supplement. Exp Eye Res 65, 57-62.
204. LaRowe, TL, Mares, JA, Snodderly, DM, Klein, ML, Wooten, BR, and Chappell, R, 2008. Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women’s health initiative. Ophthalmology 115, 876-883 e871.
205. Leuenberger, MG, Engeloch-Jarret, C, and Woggon, WD, 2001. The reaction mechanism of the enzymecatalyzed central cleavage of beta-carotene to retinal. Angew Chem Int Ed Engl 40, 2613-2617.
206. Leung, IY, Sandstrom, MM, Zucker, CL, Neuringer, M, and Snodderly, DM, 2004. Nutritional manipulation of primate retinas, II: Effects of age, n-3 fatty acids, lutein, and zeaxanthin on retinal pigment epithelium. Invest Ophthalmol Vis Sci 45, 3244-3256.
207. Leyon, H, Ros, AM, Nyberg, S, and Algvere, P, 1990. Reversibility of canthaxanthin deposits within the retina. Acta Ophthalmol (Copenh) 68, 607-611.
208. Li, CM, Presley, B, Zhang, XM, Dashti, N, Chung, BH, Medeiros, NE, Guidry, C, and Curcio, CA, 2005. Retina expresses microsomal triglyceride transfer protein: Implications for age-related maculopathy. J Lipid Res 46, 628-640.
209. Li, CM, Clark, ME, Chimento, MF, and Curcio, CA, 2006. Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression. Invest Ophthalmol Vis Sci 47, 3119-3128.
210. Lidebjer, C, Leanderson, P, Ernerudh, J, and Jonasson, L, 2007. Low plasma levels of oxygenated carotenoids in patients with coronary artery disease. Nutr Metab Cardiovasc Dis 17, 448-456.
211. Lindqvist, A and Andersson, S, 2002. Biochemical properties of purified recombinant human beta-carotene 15,15′-monooxygenase. J Biol Chem 277, 23942-23948.
212. Loane, E, Nolan, JM, O’Donovan, O, Bhosale, P, Bernstein, PS, and Beatty, S, 2008. Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration. Surv Ophthalmol 53, 68-81.
213. Lorenzi, I, von Eckardstein, A, Cavelier, C, Radosavljevic, S, and Rohrer, L, 2008. Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: Roles of ATP-binding cassette transporter A1 and scavenger receptor BI. J Mol Med 86, 171-183.
214. Lornejad-Schafer, MR, Lambert, C, Breithaupt, DE, Biesalski, HK, and Frank, J, 2007. Solubility, uptake and biocompatibility of lutein and zeaxanthin delivered to cultured human retinal pigment epithelial cells in tween40 micelles. Eur J Nutr 46, 79-86.
215. Lotery, A and Trump, D, 2007. Progress in defining the molecular biology of age related macular degeneration. Hum Genet 122, 219-236.
216. Lowe, GM, Booth, LA, Young, AJ, and Bilton, RF, 1999. Lycopene and beta-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses. Free Radic Res 30, 141-151.
217. Maccarrone, M, Bari, M, Gasperi, V, and Demmig-Adams, B, 2005. The photoreceptor protector zeaxanthin induces cell death in neuroblastoma cells. Anticancer Res 25, 3871-3876.
218. Maiti, P, Kong, J, Kim, SR, Sparrow, JR, Allikmets, R, and Rando, RR, 2006. Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation. Biochemistry 45, 852-860.
219. Malek, G, Li, CM, Guidry, C, Medeiros, NE, and Curcio, CA, 2003. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol 162, 413-425.
220. Maminishkis, A, Chen, S, Jalickee, S, Banzon, T, Shi, G, Wang, FE, Ehalt, T, Hammer, JA, and Miller, SS, 2006. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci 47, 3612-3624.
221. Mardones, P and Rigotti, A, 2004. Cellular mechanisms of vitamin E uptake: Relevance in alpha-tocopherol metabolism and potential implications for disease. J Nutr Biochem 15, 252-260.
222. Mares-Perlman, JA, Brady, WE, Klein, R, Klein, BE, Bowen, P, Stacewicz-Sapuntzakis, M, and Palta, M, 1995. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol 113, 1518-1523.
223. Mares-Perlman, JA, Fisher, AI, Klein, R, Block, G, Millen, AE, and Wright, JD, 2001. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 153, 424-432.
224. Marin-Castano, ME, Striker, GE, Alcazar, O, Catanuto, P, Espinosa-Heidmann, DG, and Cousins, SW, 2006. Repetitive nonlethal oxidant injury to retinal pigment epithelium decreased extracellular matrix turnover in vitro and induced sub-RPE deposits in vivo. Invest Ophthalmol Vis Sci 47, 4098-4112.
225. Marques, SA, Loureiro, APM, Gornes, OF, Garcia, CCM, Di Mascio, P, and Medeiros, MHG, 2004. Induction of 1, N-2-etheno-2′-deoxyguanosine in DNA exposed to beta-carotene oxidation products. FEBS Lett 560, 125-130.
226. Marshall, J, Grindle, J, Ansell, PL, and Borwein, B, 1979. Convolution in human rods—Aging process. Br J Ophthalmol 63, 181-187.
227. Mata, NL, Weng, J, and Travis, GH, 2000. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci U S A 97, 7154-7159.
228. Mata, NL, Tzekov, RT, Liu, XR, Weng, J, Birch, DG, and Travis, GH, 2001. Delayed. dark-adaptation and lipofuscin accumulation in abcr+/− mice: Implications for involvement of ABCR in age-related macular degeneration. Invest Ophthalmol Vis Sci 42, 1685-1690.
229. Matsumoto, A, Mizukami, H, Mizuno, S, Umegaki, K, Nishikawa, J, Shudo, K, Kagechika, H, and Inoue, M, 2007. Beta-cryptoxanthin, a novel natural RAR ligand, induces ATP-binding cassette transporters in macrophages. Biochem Pharmacol 74, 256-264.
230. Matsumoto, N, Kitayama, H, Kitada, M, Kimura, K, Noda, M, and Ide, C, 2003. Isolation of a set of genes expressed in the choroid plexus of the mouse using suppression subtractive hybridization. Neuroscience 117, 405-415.
231. McClure, TD and Liebler, DC, 1995. Electron capture negative chemical ionization mass spectrometry and tandem mass-spectrometry analysis of beta-carotene, alpha-tocopherol and their oxidation products. J Mass Spectrom 30, 1480-1488.
232. McDevitt, TM, Tchao, R, Harrison, EH, and Morel, DW, 2005. Carotenoids normally present in serum inhibit proliferation and induce differentiation of a human monocyte/macrophage cell line (U937). J Nutr 135, 160-164.
233. Miller, JW, Walsh, AW, Kramer, M, Hasan, T, Michaud, N, Flotte, TJ, Haimovici, R, and Gragoudas, ES, 1995. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 113, 810-818.
234. Mitchell, P, Wang, JJ, Smith, W, and Leeder, SR, 2002. Smoking and the 5-year incidence of age-related maculopathy—The Blue Mountains Eye Study. Arch Ophthalmol 120, 1357-1363.
235. Moeller, SM, Parekh, N, Tinker, L, Ritenbaugh, C, Blodi, B, Wallace, RB, and Mares, JA, 2006. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): Ancillary study of the Women’s Health Initiative. Arch Ophthalmol 124, 1151-1162.
236. Momma, Y, Nagineni, CN, Chin, MS, Srinivasan, K, Detrick, B, and Hooks, JJ, 2003. Differential expression of chemokines by human retinal pigment epithelial cells infected with cytomegalovirus. Invest Ophthalmol Vis Sci 44, 2026-2033.
237. Mordi, RC, Walton, JC, Burton, GW, Hughes, L, Ingold, KU, and Lindsay, DA, 1991. Exploratory study of beta-carotene autoxidation. Tetrahedron Lett 32, 4203-4206.
238. Mordi, RC, Walton, JC, Burton, GW, Hughes, L, Ingold, KU, Lindsay, DA, and Moffatt, DJ, 1993. Oxidative degradation of beta-carotene and beta-apo-8′-carotenal. Tetrahedron 49, 911-928.
239. Morris, MS, Jacques, PF, Chylack, LT, Hankinson, SE, Willett, WC, Hubbard, LD, and Taylor, A, 2007. Intake of zinc and antioxidant micronutrients and early age-related maculopathy lesions. Ophthalmic Epidemiol 14, 288-298.
240. Moshfeghi, DM and Blumenkranz, MS, 2007. Role of genetic factors and inflammation in age-related macular degeneration. Retina 27, 269-275.
241. Mukherjee, PK, Marcheselli, VL, de Rivero Vaccari, JC, Gordon, WC, Jackson, FE, and Bazan, NG, 2007. Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis. Proc Natl Acad Sci U S A 104, 13158-13163.
242. Mullins, RF, 2007. Genetic insights into the pathobiology of age-related macular degeneration. Int Ophthalmol Clin 47, 1-14.
243. Murata, M and Kawanishi, S, 2000. Oxidative DNA damage by vitamin A and its derivative via superoxide generation. J Biol Chem 275, 2003-2008.
244. Nagao, A, 2004. Oxidative conversion of carotenoids to retinoids and other products. J Nutr 134, 237S-240.
245. Nolan, JM, Stack, J, O, OD, Loane, E, and Beatty, S, 2007. Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 84, 61-74.
246. Nozaki, M, Raisler, BJ, Sakurai, E, Sarma, JV, Barnum, SR, Lambris, JD, Chen, Y, Zhang, K, Ambati, BK, Baffi, JZ, and Ambati, J, 2006. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A 103, 2328-2333.
247. O’Sullivan, L, Ryan, L, and O’Brien, N, 2007. Comparison of the uptake and secretion of carotene and xanthophyll carotenoids by Caco-2 intestinal cells. Br J Nutr 98, 38-44.
248. Obana, A, Hiramitsu, T, Gohto, Y, Ohira, A, Mizuno, S, Hirano, T, Bernstein, PS, Fujii, H, Iseki, K, Tanito, M, and Hotta, Y, 2008. Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population. Ophthalmology 115, 147-157.
249. Ojima, F, Sakamoto, H, Ishiguro, Y, and Terao, J, 1993. Consumption of carotenoids in photosensitized oxidation of human plasma and plasma low-density-lipoprotein. Free Radic Biol Med 15, 377-384.
250. Omenn, GS, 1996. Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med 335, 1067-1068.
251. Omenn, GS, Goodman, GE, Thornquist, MD, Balmes, J, Cullen, MR, Glass, A, Keogh, JP, Meyskens, FL, Valanis, B, Williams, JH, Barnhart, S, Cherniack, MG, Brodkin, CA, and Hammar, S, 1996. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 88, 1550-1559.
252. Owens, SL, Bunce, C, Brannon, AJ, Xing, W, Chisholm, IH, Gross, M, Guymer, RH, Holz, FG, and Bird, AC, 2006. Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: Final results of the drusen laser study. Am J Ophthalmol 141, 276-281.
253. Owsley, C, Jackson, GR, White, M, Feist, R, and Edwards, D, 2001. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology 108, 1196-1202.
254. Owsley, C, McGwin, G, Jackson, GR, Heimburger, DC, Piyathilake, CJ, Klein, R, White, MF, and Kallies, K, 2006. Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy. Invest Ophthalmol Vis Sci 47, 1310-1318.
255. Palozza, P, Calviello, G, and Bartoli, GM, 1995. Prooxidant activity of beta-carotene under 100-percent oxygen pressure in rat liver microsomes. Free Radic Biol Med 19, 887-892.
256. Palozza, P, Luberto, C, Calviello, G, Ricci, P, and Bartoli, GM, 1997. Antioxidant and prooxidant role of betacarotene in murine normal and tumor thymocytes: Effects of oxygen partial pressure. Free Radic Biol Med 22, 1065-1073.
257. Palozza, P, 1998. Prooxidant actions of carotenoids in biologic systems. Nutr Rev 56, 257-265.
258. Palozza, P, Calviello, G, Serini, S, Maggiano, N, Lanza, P, Ranelletti, FO, and Bartoli, GM, 2001. Beta-carotene at high concentrations induces apoptosis by enhancing oxy-radical production in human adenocarcinoma cells. Free Radic Biol Med 30, 1000-1007.
259. Palozza, P, Serini, S, and Calviello, G, 2006. Carotenoids as modulators of intracellular signaling pathways. Curr Signal Transduct Ther 1, 325-335.
260. Panzella, L, Manini, P, Napolitano, A, and d’Ischia, M, 2004. Free radical oxidation of (E)-retinoic acid by the Fenton reagent: Competing epoxidation and oxidative breakdown pathways and novel products of 5,6-epoxyretinoic acid transformation. Chem Res Toxicol 17, 1716-1724.
261. Parisi, V, Tedeschi, M, Gallinaro, G, Varano, M, Saviano, S, and Piermarocchi, S, 2008. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology 115, 324-333 e322.
262. Parker, RS, 1996. Absorption, metabolism, and transport of carotenoids. FASEB J 10, 542-551.
263. Philips, N, Keller, T, Hendrix, C, Hamilton, S, Arena, R, Tuason, M, and Gonzalez, S, 2007. Regulation of the extracellular matrix remodeling by lutein in dermal fibroblasts, melanoma cells, and ultraviolet radiation exposed fibroblasts. Arch Dermatol Res 299, 373-379.
264. Polyakov, NE, Leshina, TV, Konovalova, TA, and Kispert, LD, 2001. Carotenoids as scavengers of free radicals in a Fenton reaction: Antioxidants or pro-oxidants? Free Radic Biol Med 31, 398-404.
265. Prasain, JK, Moore, R, Hurst, JS, Barnes, S, and van Kuijk, F, 2005. Electrospray tandem mass spectrometric analysis of zeaxanthin and its oxidation products. J Mass Spectrom 40, 916-923.
266. Provost, AC, Pequignot, MO, Sainton, KM, Gadin, S, Salle, S, Marchant, D, Hales, DB, and Abitbol, M, 2003. Expression of SR-BI receptor and StAR protein in rat ocular tissues. C R Biol 326, 841-851.
267. Radu, RA, Mata, NL, Nusinowitz, S, Liu, X, Sieving, PA, and Travis, GH, 2003. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt’s macular degeneration. Proc Natl Acad Sci U S A 100, 4742-4747.
268. Radu, RA, Han, Y, Bui, TV, Nusinowitz, S, Bok, D, Lichter, J, Widder, K, Travis, GH, and Mata, NL, 2005. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: A potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci 46, 4393-4401.
269. Rafi, MM and Shafaie, Y, 2007. Dietary lutein modulates inducible nitric oxide synthase (iNOS) gene and protein expression in mouse macrophage cells (RAW 264.7). Mol Nutr Food Res 51, 333-340.
270. Rapp, LM, Maple, SS, and Choi, JH, 2000. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci 41, 1200-1209.
271. Reading, VM and Weale, RA, 1974. Macular pigment and chromatic aberration. J Opt Soc Am 64, 231-234.
272. Reboul, E, Abou, L, Mikail, C, Ghiringhelli, O, Andre, M, Portugal, H, Jourdheuil-Rahmani, D, Amiot, MJ, Lairon, D, and Borel, P, 2005. Lutein transport by Caco-2 TC-7 cells occurs partly by a facilitated process involving the scavenger receptor class B type I (SR-BI). Biochem J 387, 455-461.
273. Reboul, E, Klein, A, Bietrix, F, Gleize, B, Malezet-Desmoulins, C, Schneider, M, Margotat, A, Lagrost, L, Collet, X, and Borel, P, 2006. Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J Biol Chem 281, 4739-4745.
274. Reboul, E, Thap, S, Perrot, E, Amiot, MJ, Lairon, D, and Borel, P, 2007a. Effect of the main dietary antioxidants (carotenoids, gamma-tocopherol, polyphenols, and vitamin C) on alpha-tocopherol absorption. Eur J Clin Nutr 61, 1167-1173.
275. Reboul, E, Thap, S, Tourniaire, F, Andre, M, Juhel, C, Morange, S, Amiot, MJ, Lairon, D, and Borel, P, 2007b. Differential effect of dietary antioxidant classes (carotenoids, polyphenols, vitamins C and E) on lutein absorption. Br J Nutr 97, 440-446.
276. Redmond, RW and Kochevar, IE, 2006. Spatially resolved cellular responses to singlet oxygen. Photochem Photobiol 82, 1178-1186.
277. Richer, S, Stiles, W, Statkute, L, Pulido, J, Frankowski, J, Rudy, D, Pei, K, Tsipursky, M, and Nyland, J, 2004. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75, 216-230.
278. Richer, S, Devenport, J, and Lang, JC, 2007. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Optometry 78, 213-219.
279. Roberts, JE, Kukielczak, BM, Hu, DN, Miller, DS, Bilski, P, Sik, RH, Motten, AG, and Chignell, CF, 2002. The role of A2E in prevention or enhancement of light damage in human retinal pigment epithelial cells. Photochem Photobiol 75, 184-190.
280. Robman, L, Vu, H, Hodge, A, Tikellis, G, Dimitrov, P, McCarty, C, and Guymer, R, 2007. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can J Ophthalmol 42, 720-726.
281. Rodriguez-Carmona, M, Kvansakul, J, Harlow, JA, Kopcke, W, Schalch, W, and Barbur, JL, 2006. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision. Ophthalmic Physiol Opt 26, 137-147.
282. Rozanowska, M, Jarvis-Evans, J, Korytowski, W, Boulton, ME, Burke, JM, and Sarna, T, 1995. Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem 270, 18825-18830.
283. Rozanowska, M, Wessels, J, Boulton, M, Burke, JM, Rodgers, MA, Truscott, TG, and Sarna, T, 1998. Blue light-induced singlet oxygen generation by retinal lipofuscin in non-polar media. Free Radic Biol Med 24, 1107-1112.
284. Rozanowska, M, Korytowski, W, Rozanowski, B, Skumatz, C, Boulton, ME, Burke, JM, and Sarna, T, 2002. Photoreactivity of aged human RPE melanosomes: A comparison with lipofuscin. Invest Ophthalmol Vis Sci 43, 2088-2096.
285. Rozanowska, M, Pawlak, A, Rozanowski, B, Skumatz, C, Zareba, M, Boulton, ME, Burke, JM, Sarna, T, and Simon, JD, 2004a. Age-related changes in the photoreactivity of retinal lipofuscin granules: Role of chloroform-insoluble components. Invest Ophthalmol Vis Sci 45, 1052-1060.
286. Rozanowska, M and Sarna, T, 2005. Light-induced damage to the retina: Role of rhodopsin chromophore revisited. Photochem Photobiol 81, 1305-1330.
287. Różanowska, M and Różanowski, B, 2008. Visual transduction and age-related changes in lipofuscin. In: Tombran-Tink, J and Barnstable, CJ (Eds.), Ophthalmology Research: The Visual Transduction Cascade. The Humana Press Inc., Totowa, NJ, pp. 405-446.
288. Rozanowska, MB, Bigaj, J, Boulton, ME, Czuba-Pelech, B, Landrum, J, Rozanowski, B, and Zareba, M, 2004b. Uptake of carotenoids and their antioxidant action in ARPE-19 cells in culture. Invest Ophthalmol Vis Sci 45, U531.
289. Rozanowski, B and Rozanowska, M, 2005. Degradation products of xanthophyll include blue-light absorbing photosensitizers. Invest Ophthalmol Vis Sci 46, E-Abstract 3032.
290. Rozanowski, B, Burke, J, Sarna, T, and Rozanowska, M, 2008a. The pro-oxidant effects of interactions of ascorbate with photoexcited melanin fade away with aging of the retina. Photochem Photobiol 84, 658-670.
291. Rozanowski, B, Burke, JM, Boulton, ME, Sarna, T, and Rozanowska, M, 2008b. Human RPE melanosomes protect from photosensitized and iron-mediated oxidation but become pro-oxidant in the presence of iron upon photodegradation. Invest Ophthalmol Vis Sci 49, 2838-2847.
292. Rozanowski, B, Cuenco, J, Davies, S, Shamsi, FA, Zadlo, A, Dayhaw-Barker, P, Rozanowska, M, Sarna, T, and Boulton, ME, 2008c. The phototoxicity of aged human retinal melanosomes. Photochem Photobiol 84, 650-657.
293. Ryeom, SW, Silverstein, RL, Scotto, A, and Sparrow, JR, 1996a. Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J Biol Chem 271, 20536-20539.
294. Ryeom, SW, Sparrow, JR, and Silverstein, RL, 1996b. CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. J Cell Sci 109, 387-395.
295. Sakaguchi, H, Miyagi, M, Shadrach, KG, Rayborn, ME, Crabb, JW, and Hollyfield, JG, 2002. Clusterin is present in drusen in age-related macular degeneration. Exp Eye Res 74, 547-549.
296. Salerno, C, Crifo, C, Capuozzo, E, Sommerburg, O, Langhans, CD, and Siems, W, 2005. Effect of carotenoid oxidation products on neutrophil viability and function. Biofactors 24, 185-192.
297. Sanders, TA, Haines, AP, Wormald, R, Wright, LA, and Obeid, O, 1993. Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr 57, 428-433.
298. SanGiovanni, JP, Chew, EY, Clemons, TE, Ferris, FL, 3rd, Gensler, G, Lindblad, AS, Milton, RC, Seddon, JM, and Sperduto, RD, 2007. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study, AREDS Report No. 22. Arch Ophthalmol 125, 1225-1232.
299. Santocono, M, Zurria, M, Berrettini, M, Fedeli, D, and Falcioni, G, 2006. Influence of astaxanthin, zeaxanthin and lutein on DNA damage and repair in UVA-irradiated cells. J Photochem Photobiol B 85, 205-215.
300. Santos, MS, Meydani, SN, Leka, L, Wu, DY, Fotouhi, N, Meydani, M, Hennekens, CH, and Gaziano, JM, 1996. Natural killer cell activity in elderly men is enhanced by beta-carotene supplementation. Am J Clin Nutr 64, 772-777.
301. Santos, MS, Gaziano, JM, Leka, LS, Beharka, AA, Hennekens, CH, and Meydani, SN, 1998. Beta-caroteneinduced enhancement of natural killer cell activity in elderly men: An investigation of the role of cytokines. Am J Clin Nutr 68, 164-170.
302. Sanz, MM, Johnson, LE, Ahuja, S, Ekstrom, PA, Romero, J, and van Veen, T, 2007. Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration. Neuroscience 145, 1120-1129.
303. Sarkadi, B, Homolya, L, Szakacs, G, and Varadi, A, 2006. Human multidrug resistance ABCB and ABCG transporters: Participation in a chemoimmunity defense system. Physiol Rev 86, 1179-1236.
304. Scallon, LJ, Burke, JM, Mieler, WF, Kies, JC, and Aaberg, TM, 1988. Canthaxanthine-induced retinal pigment epithelial changes in the cat. Curr Eye Res 7, 687-693.
305. Schadel, SA, Heck, M, Maretzki, D, Filipek, S, Teller, DC, Palczewski, K, and Hofmann, KP, 2003. Ligand channeling within a G-protein-coupled receptor—The entry and exit of retinals in native opsin. J Biol Chem 278, 24896-24903.
306. Schmitz-Valckenberg, S, Bindewald-Wittich, A, Dolar-Szczasny, J, Dreyhaupt, J, Wolf, S, Scholl, HP, and Holz, FG, 2006. Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci 47, 2648-2654.
307. Scholl, HPN, Fleckenstein, M, Issa, PC, Keilhauer, C, Holz, FG, and Weber, BHF, 2007. An update on the genetics of age-related macular degeneration. Mol Vis 13, 196-205.
308. Seddon, JM, Ajani, UA, Sperduto, RD, Hiller, R, Blair, N, Burton, TC, Farber, MD, Gragoudas, ES, Haller, J, Miller, DT, Yannuzzi, LA, and Willett, W, 1994. Dietary carotenoids, vitamin A, vitamin C, and vitamin E, and advanced age-related macular degeneration. J Am Med Assoc 272, 1413-1420.
309. Seddon, JM, Gensler, G, Milton, RC, Klein, ML, and Rifai, N, 2004. Association between C-reactive protein and age-related macular degeneration. J Am Med Assoc 291, 704-710.
310. Seddon, JM, Gensler, G, Klein, ML, and Milton, RC, 2006. C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. Nutrition 22, 441-443.
311. Seddon, JM, 2007. Multivitamin-multimineral supplements and eye disease: age-related macular degeneration and cataract. Am J Clin Nutr 85, 304S-307S.
312. Selvaraj, RK and Klasing, KC, 2006. Lutein and eicosapentaenoic acid interact to modify iNOS mRNA levels through the PPAR gamma/RXR pathway in chickens and HD11 cell lines. J Nutr 136, 1610-1616.
313. Selvaraj, RK, Koutsos, EA, Calvert, CC, and Klasing, KC, 2006. Dietary lutein and fat interact to modify macrophage properties in chicks hatched from carotenoid deplete or replete eggs. J Anim Physiol Anim Nutr (Berl) 90, 70-80.
314. Shafaa, MW, Diehl, HA, and Socaciu, C, 2007. The solubilisation pattern of lutein, zeaxanthin, canthaxanthin and beta-carotene differ characteristically in liposomes, liver microsomes and retinal epithelial cells. Biophys Chem 129, 111-119.
315. Sharoni, Y, Danilenko, M, Dubi, N, Ben-Dor, A, and Levy, J, 2004. Carotenoids and transcription. Arch Biochem Biophys 430, 89-96.
316. Siems, W, Sommerburg, O, Schild, L, Augustin, W, Langhans, CD, and Wiswedel, I, 2002. Beta-carotene cleavage products induce oxidative stress in vitro by impairing mitochondrial respiration. Faseb J 16, U335-U353.
317. Siems, W, Capuozzo, E, Crifo, C, Sommerburg, O, Langhans, CD, Schlipalius, L, Wiswedel, I, Kraemer, K, and Salerno, C, 2003. Carotenoid cleavage products modify respiratory burst and induce apoptosis of human neutrophils. Biochim Biophys Acta 1639, 27-33.
318. Siems, W, Wiswedel, I, Salerno, C, Crifo, C, Augustin, W, Schild, L, Langhans, CD, and Sommerburg, O, 2005. Beta-carotene breakdown products may impair mitochondrial functions—Potential side effects of highdose beta-carotene supplementation. J Nutr Biochem 16, 385-397.
319. Siems, WG, Sommerburg, O, and van Kuijk, F, 1999. Lycopene and beta-carotene decompose more rapidly than lutein and zeaxanthin upon exposure to various pro-oxidants in vitro. Biofactors 10, 105-113.
320. Siems, WG, Sommerburg, O, Hurst, JS, and van Kuijk, F, 2000. Carotenoid oxidative degradation products inhibit Na+-K+-ATPase. Free Radic Res 33, 427-435.
321. Snellen, EL, Verbeek, AL, Van Den Hoogen, GW, Cruysberg, JR, and Hoyng, CB, 2002. Neovascular agerelated macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand 80, 368-371.
322. Snodderly, DM, Auran, JD, and Delori, FC, 1984a. The macular pigment.2. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25, 674-685.
323. Snodderly, DM, Brown, PK, Delori, FC, and Auran, JD, 1984b. The macular pigment.1. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25, 660-673.
324. Sommerburg, O, Siems, WG, Hurst, JS, Lewis, JW, Kliger, DS, and van Kuijk, F, 1999. Lutein and zeaxanthin are associated with photoreceptors in the human retina. Curr Eye Res 19, 491-495.
325. Sommerburg, O, Langhans, CD, Arnhold, J, Leichsenring, M, Salerno, C, Crifo, C, Hoffmann, GF, Debatin, KM, and Siems, WG, 2003. Beta-carotene cleavage products after oxidation mediated by hypochlorous acid—A model for neutrophil-derived degradation. Free Radic Biol Med 35, 1480-1490.
326. Sperduto, RD, 1993. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 111, 104-109.
327. Stahl, W, Junghans, A, de Boer, B, Driomina, ES, Briviba, K, and Sies, H, 1998. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: Synergistic effects of lycopene and lutein. FEBS Lett 427, 305-308.
328. Stahl, W and Sies, H, 2005. Bioactivity and protective effects of natural carotenoids. Biochim Biophys Acta-Mol Basis Dis 1740, 101-107.
329. Stratton, SP, Schaefer, WH, and Liebler, DC, 1993. Isolation and identification of singlet oxygen oxidationproducts of beta-carotene. Chem Res Toxicol 6, 542-547.
330. Strauss, O, 2005. The retinal pigment epithelium in visual function. Physiol Rev 85, 845-881.
331. Sumantran, VN, Zhang, R, Lee, DS, and Wicha, MS, 2000. Differential regulation of apoptosis in normal versus transformed mammary epithelium by lutein and retinoic acid. Cancer Epidemiol Biomarkers Prev 9, 257-263.
332. Sun, Z and Yao, H, 2007. The influence of di-acetylation of the hydroxyl groups on the anti-tumor-proliferation activity of lutein and zeaxanthin. Asia Pac J Clin Nutr 16(Suppl 1), 447-452.
333. Sundelin, SP and Nilsson, SE, 2001. Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants. Free Radic Biol Med 31, 217-225.
334. Suuronen, T, Nuutinen, T, Ryhanen, T, Kaarniranta, K, and Salminen, A, 2007. Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells. Biochem Biophys Res Commun 357, 397-401.
335. Swaroop, A, Branham, KEH, Chen, W, and Abecasis, G, 2007. Genetic susceptibility to age-related macular degeneration: A paradigm for dissecting complex disease traits. Hum Mol Genet 16, R174-R182.
336. Tan, JS, Wang, JJ, Flood, V, Rochtchina, E, Smith, W, and Mitchell, P, 2008. Dietary antioxidants and the long-term incidence of age-related macular degeneration: The Blue Mountains Eye Study. Ophthalmology 115, 334-341.
337. Tangirala, RK, Pratico, D, FitzGerald, GA, Chun, S, Tsukamoto, K, Maugeais, C, Usher, DC, Pure, E, and Rader, DJ, 2001. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem 276, 261-266.
338. Tapiero, H, Townsend, DM, and Tew, KD, 2004. The role of carotenoids in the prevention of human pathologies. Biomed Pharmacother 58, 100-110.
339. Thakkinstian, A, Bowe, S, McEvoy, M, Smith, W, and Attia, J, 2006. Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis. Am J Epidemiol 164, 813-822.
340. Thornton, J, Edwards, R, Mitchell, P, Harrison, RA, Buchan, I, and Kelly, SP, 2005. Smoking and age-related macular degeneration: A review of association. Eye 19, 935-944.
341. Tomany, SC, Wang, HJ, van Leeuwen, R, Klein, R, Mitchell, P, Vingerling, JR, Klein, BEK, Smith, W, and de Jong, P, 2004. Risk factors for incident age-related macular degeneration—Pooled findings from 3 continents. Ophthalmology 111, 1280-1287.
342. Travis, GH, Golczak, M, Moise, AR, and Palczewski, K, 2007. Diseases caused by defects in the visual cycle: Retinoids as potential therapeutic agents. Annu Rev Pharmacol Toxicol 47, 469-512.
343. Trieschmann, M, Beatty, S, Nolan, JM, Hense, HW, Heimes, B, Austermann, U, Fobker, M, and Pauleikhoff, D, 2007. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: The LUNA study. Exp Eye Res 84, 718-728.
344. Trumbo, PR and Ellwood, KC, 2006. Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: An evaluation using the Food and Drug Administration’s evidence-based review system for health claims. Am J Clin Nutr 84, 971-974.
345. Tserentsoodol, N, Gordiyenko, NV, Pascual, I, Lee, JW, Fliesler, SJ, and Rodriguez, IR, 2006a. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol Vis 12, 1319-1333.
346. Tserentsoodol, N, Sztein, J, Campos, M, Gordiyenko, NV, Fariss, RN, Lee, JW, Fliesler, SJ, and Rodriguez, IR, 2006b. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptormediated process. Mol Vis 12, 1306-1318.
347. Uittenbogaard, A, Everson, WV, Matveev, SV, and Smart, EJ, 2002. Cholesteryl ester is transported from caveolae to internal membranes as part of a caveolin-annexin II lipid-protein complex. J Biol Chem 277, 4925-4931.
348. van Bennekum, A, Werder, M, Thuahnai, ST, Han, CH, Duong, P, Williams, DL, Wettstein, P, Schulthess, G, Phillips, MC, and Hauser, H, 2005. Class B scavenger receptor-mediated intestinal absorption of dietary ss-carotene and cholesterol. Biochemistry 44, 4517-4525.
349. van de Kerkhof, EG, de Graaf, IAM, and Groothuis, GMM, 2007. In vitro methods to study intestinal drug metabolism. Curr Drug Metab 8, 658-675.
350. van Leeuwen, R, Klaver, CC, Vingerling, JR, Hofman, A, and de Jong, PT, 2003. Epidemiology of age-related maculopathy: A review. Eur J Epidemiol 18, 845-854.
351. van Soest, SS, de Wit, GM, Essing, AH, ten Brink, JB, Kamphuis, W, de Jong, PT, and Bergen, AA, 2007. Comparison of human retinal pigment epithelium gene expression in macula and periphery highlights potential topographic differences in Bruch’s membrane. Mol Vis 13, 1608-1617.
352. Venkateswaran, A, Laffitte, BA, Joseph, SB, Mak, PA, Wilpitz, DC, Edwards, PA, and Tontonoz, P, 2000. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A 97, 12097-12102.
353. Von Eckardstein, A, Langer, C, Engel, T, Schaukal, I, Cignarella, A, Reinhardt, J, Lorkowski, S, Li, Z, Zhou, X, Cullen, P, and Assmann, G, 2001. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. FASEB J 15, 1555-1561.
354. von Recum, HA, Okano, T, Kim, SW, and Bernstein, PS, 1999. Maintenance of retinoid metabolism in human retinal pigment epithelium cell culture. Exp Eye Res 69, 97-107.
355. Vu, HT, Robman, L, McCarty, CA, Taylor, HR, and Hodge, A, 2006. Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project. Br J Ophthalmol 90, 389-390.
356. Walston, J, Xue, Q, Semba, RD, Ferrucci, L, Cappola, AR, Ricks, M, Guralnik, J, and Fried, LP, 2006. Serum antioxidants, inflammation, and total mortality in older women. Am J Epidemiol 163, 18-26.
357. Wang, N and Anderson, RE, 1993. Transport of 22:6n-3 in the plasma and uptake into retinal pigment epithelium and retina. Exp Eye Res 57, 225-233.
358. Wang, W, Connor, SL, Johnson, EJ, Klein, ML, Hughes, S, and Connor, WE, 2007. Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. Am J Clin Nutr 85, 762-769.
359. Webb, NR, Connell, PM, Graf, GA, Smart, EJ, de Villiers, WJ, de Beer, FC, and van der Westhuyzen, DR, 1998. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem 273, 15241-15248.
360. Weng, J, Mata, NL, Azarian, SM, Tzekov, RT, Birch, DG, and Travis, GH, 1999. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt’s disease from the phenotype in abcr knockout mice. Cell 98, 13-23.
361. Wenzel, JJ, Kaminski, WE, Piehler, A, Heimerl, S, Langmann, T, and Schmitz, G, 2003. ABCA10, a novel cholesterol-regulated ABCA6-like ABC transporter. Biochem Biophys Res Commun 306, 1089-1098.
362. Werner, JS, Donnelly, SK, and Kliegl, R, 1987. Aging and human macular pigment density. Vision Res 27, 257-268.
363. West, AL, Oren, GA, and Moroi, SE, 2006. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol 141, 157-166.
364. Wiggs, JL, 2006. Complement factor H and macular degeneration—The genome yields an important clue. Arch Ophthalmol 124, 577-578.
365. Wong, P, Pfeffer, BA, Bernstein, SL, Chambers, ML, Chader, GJ, Zakeri, ZF, Wu, YQ, Wilson, MR, and Becerra, SP, 2000. Clusterin protein diversity in the primate eye. Mol Vis 6, 184-191.
366. Wong, P, Ulyanova, T, Organisciak, DT, Bennett, S, Lakins, J, Arnold, JM, Kutty, RK, Tenniswood, M, vanVeen, T, Darrow, RM, and Chader, G, 2001. Expression of multiple forms of clusterin during lightinduced retinal degeneration. Curr Eye Res 23, 157-165.
367. Wong, RW, Richa, DC, Hahn, P, Green, WR, and Dunaief, JL, 2007. Iron toxicity as a potential factor in AMD. Retina 27, 997-1003.
368. Wooten, BR and Hammond, BR, 2002. Macular pigment: influences on visual acuity and visibility. Prog Retin Eye Res 21, 225-240.
369. Wrona, M, Korytowski, W, Rozanowska, M, Sarna, T, and Truscott, TG, 2003. Cooperation of antioxidants in protection against photosensitized oxidation. Free Radic Biol Med 35, 1319-1329.
370. Wrona, M, Rozanowska, M, and Sarna, T, 2004. Zeaxanthin in combination with ascorbic acid or alphatocopherol protects ARPE-19 cells against photosensitized peroxidation of lipids. Free Radic Biol Med 36, 1094-1101.
371. Yemelyanov, AY, Katz, NB, and Bernstein, PS, 2001. Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp Eye Res 72, 381-392.
372. Yeoh, J, Sims, J, and Guymer, RH, 2006. A review of drug options in age-related macular degeneration therapy and potential new agents. Expert Opin Pharmacother 7, 2355-2368.
373. Yonekura, L, Tsuzuki, W, and Nagao, A, 2006. Acyl moieties modulate the effects of phospholipids on beta-carotene uptake by Caco-2 cells. Lipids 41, 629-636.
374. Yonekura, L and Nagao, A, 2007. Intestinal absorption of dietary carotenoids. Mol Nutr Food Res 51, 107-115.
375. Young, AJ and Lowe, GM, 2001. Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys 385, 20-27.
376. Zannis, VI, Chroni, A, and Krieger, M, 2006. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med 84, 276-294.
377. Zarbin, MA, 2004. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122, 598-614.